Enanta Pharmaceuticals Inc
ENTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001177648
No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Enanta Pharmaceuticals Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 132 | 106 | −26 |
| Shares | 20.1M | 20.0M | −113.0K (−0.6%) |
| Value | $225.0M | $188.4M | −$36.5M (−16.2%) |
New holders (15)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 300,000 | $2.82M | 0.26% |
| Federated Hermes, Inc. | 133,189 | $1.25M | 0.00% |
| Man Group plc | 42,415 | $399.1K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 41,365 | $389.2K | 0.00% |
| Pennant Investors, LP | 35,100 | $330.3K | 0.10% |
| Engineers Gate Manager LP | 27,895 | $262.5K | 0.01% |
| Nebula Research & Development LLC | 18,468 | $173.8K | 0.05% |
| Diversified Trust Co | 16,900 | $159.0K | 0.01% |
| Quest Partners LLC | 15,465 | $145.5K | 0.03% |
| Graham Capital Management, L.P. | 13,360 | $125.7K | 0.00% |
| Brevan Howard Capital Management LP | 12,391 | $116.6K | 0.01% |
| American Century Companies Inc | 10,630 | $100.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 1,200 | $11.3K | 0.00% |
| Simplex Trading, LLC | 739 | $6.00K | 0.00% |
| GAMMA Investing LLC | 43 | $522 | 0.00% |
Sold out (41)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q3 2023 and filed for Q4 2023 without it.